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Despite continuing advances in the resoiution and sensitivity of modern scanners, the role of ultrasound in the breast clinic is limited by the inability of current ultrasound practice to reliably visualize MCs. While x-ray mammography is currently the gold standard for their detection, approximately 70% of breast biopsies prompted by the presentation of hlCs result in negative biopsy. [2, 3] . Our goal has been to extend and refine this approach using both theoretical and clinical result,s in the interest of improving 51C visualization with ultrasound. When the Faran model is applied using the acoustic parameters of calcium hydroxyapatite, the primary constituent of MCs [4] , and tissue, the resulting echo magnit,ude spectrum exhibits the prominent, peaks and nulls that distinguish elastic from inelastic scattering, as shown in Fig. 1 [5] . We have captured RF echoes from suspected in vivo MCs. Such data has been captured from seven in viuo targets among four volunteer subjects to date [5] . The echo spectra of six of these targets show markedly elastic character.
The magnitude spectrum of the echo from a suspected in vivo MC is also shown in Fig. 1 . Note that this spectrum is the product of the far-field target response and the roughly Gaussian ultrasound system frequency response. 
DETECTION PERFORMANCE ANALYSIS
We have described a simple receiver operating characteristic (ROC) model of hlC detection by an ideal observer using the Rician probability density function, which is parameterized by the variable k. In our approach k is the ratio of ;LIC echo amplitude to the backscatter amplitude of the surrounding tissue[l]. Overall detection performance for different systems can then be compared based on the area -4; under the resulting ROC curves, which in turn is a function of k. For example, to achieve an A, = 0.99, the MC target echo, tissue backscatter, and system parameters must combine to provide a Ic > 5. We estimate k through a combination of the Faran model solution for hydroxyapatite, direct measurements of fibroglandular breast tissue backscatter, and simulated phase aberration [l,5] . Fig. 2 shows that the performance of a hypothetical 1-D 7.5 MHz, 60% bandwidth breast imaging transducer with 128 elements of X pitch, f/8 in elevation, and laterally apodized over the range of f/4 to f/l. The effective k values it provides are shown as a function of lateral f-number.
The performance of this array is roughly a function of the root of the aperture size. (If the array size were increased in both dimensions, performance becomes a linear function of aperture size.) These results show that for the typical patient and a 99% confidence level (requiring a Ic 2 5) the 1-D array does not provide adequate performance for the 100 pm MC. Fig. 2 also shows the scaling of the k parameter associated with different degrees of phase aberration due to velocity error, meaning the discrepancy between the true tissue velocity a.nd that assumed during beamforming.
Our studies suggest that at the range of interest in the breast, this type of phase aberration has greater impact on image quality than the random variation in phase across the array due to tissue inhomogeneities. 
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